Helmut Zarbl - Publications

Affiliations: 
Toxicology Rutgers University, New Brunswick, New Brunswick, NJ, United States 
Area:
Toxicology, Epidemiology, Bioinformatics Biology, Cell Biology
Website:
https://news.rutgers.edu/news/rutgers-names-new-environmental-and-occupational-health-sciences-institute-director/20171115#.W6EwDegzbDc

44 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Liu Y, Chen X, Gong Z, Zhang H, Fei F, Tang X, Wang J, Xu P, Zarbl H, Ren X. Is Required for Mammary Gland Development During Pregnant Periods and Affects the Morphology and Growth of Breast Cancer Cells. Frontiers in Oncology. 9: 1279. PMID 31824855 DOI: 10.3389/Fonc.2019.01279  0.317
2019 Green AL, Eid A, Zhan L, Zarbl H, Guo GL, Richardson JR. Epigenetic Regulation of the Ontogenic Expression of the Dopamine Transporter. Frontiers in Genetics. 10: 1099. PMID 31749842 DOI: 10.3389/Fgene.2019.01099  0.319
2017 Fang M, Kang HG, Park Y, Estrella B, Zarbl H. In Vitro Bioluminescence Assay to Characterize Circadian Rhythm in Mammary Epithelial Cells. Journal of Visualized Experiments : Jove. PMID 28994762 DOI: 10.3791/55832  0.342
2017 Green AL, Zhan L, Eid A, Zarbl H, Guo GL, Richardson JR. Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1. Neuropharmacology. PMID 28743636 DOI: 10.1016/J.Neuropharm.2017.07.020  0.321
2017 Fang M, Ohman Strickland PA, Kang HG, Zarbl H. Uncoupling genotoxic stress responses from circadian control increases susceptibility to mammary carcinogenesis. Oncotarget. PMID 28427145 DOI: 10.18632/Oncotarget.15678  0.314
2016 Zhang H, Fei F, Chen X, Ceng Z, Tang X, Zarbl H, Ren X. Abstract 1160: FRY Inhibits progression and metastasis of breast cancer through activating Hippo signaling pathway Cancer Research. 76: 1160-1160. DOI: 10.1158/1538-7445.Am2016-1160  0.335
2015 Fang M, Guo WR, Park Y, Kang HG, Zarbl H. Enhancement of NAD+-dependent SIRT1 deacetylase activity by methylselenocysteine resets the circadian clock in carcinogen-treated mammary epithelial cells. Oncotarget. PMID 26544624 DOI: 10.18632/Oncotarget.6002  0.352
2015 Fang MZ, Ohman-Strickland P, Kelly-McNeil K, Kipen H, Crabtree BF, Lew JP, Zarbl H. Sleep interruption associated with house staff work schedules alters circadian gene expression. Sleep Medicine. 16: 1388-94. PMID 26498241 DOI: 10.1016/J.Sleep.2015.06.011  0.322
2015 Green AL, Hossain MM, Tee SC, Zarbl H, Guo GL, Richardson JR. Epigenetic Regulation of Dopamine Transporter mRNA Expression in Human Neuroblastoma Cells. Neurochemical Research. 40: 1372-8. PMID 25963949 DOI: 10.1007/S11064-015-1601-6  0.343
2013 Ren X, Graham JC, Jing L, Mikheev AM, Gao Y, Lew JP, Xie H, Kim AS, Shang X, Friedman C, Vail G, Fang MZ, Bromberg Y, Zarbl H. Mapping of Mcs30, a new mammary carcinoma susceptibility quantitative trait locus (QTL30) on rat chromosome 12: identification of fry as a candidate Mcs gene. Plos One. 8: e70930. PMID 24023717 DOI: 10.1371/Journal.Pone.0070930  0.322
2013 Zarbl H, Kipen H, Fang M, Ohman-Strickland P, Black K, Lew J. Evaluation of circadian gene expression changes in human peripheral blood cells as biomarkers of circadian disruption in shift workers: application to studies of breast and prostate cancer chemoprevention Sleep Medicine. 14: e28-e29. DOI: 10.1016/J.Sleep.2013.11.030  0.344
2012 Graham JC, Zarbl H. Use of cell-SELEX to generate DNA aptamers as molecular probes of HPV-associated cervical cancer cells. Plos One. 7: e36103. PMID 22536456 DOI: 10.1371/Journal.Pone.0036103  0.304
2011 Zarbl H, Graham J, Ren X, Jing L, Mikheev AM, Lew JP, Gao Y, Friedman C. Abstract LB-131: Decreased nuclear localization and expression of the FRY tumor suppressor gene, a repressor of epithelial mesenchymal transition, are highly correlated with breast cancer phenotype, grade, and progression Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-131  0.375
2010 Fang MZ, Zhang X, Zarbl H. Methylselenocysteine resets the rhythmic expression of circadian and growth-regulatory genes disrupted by nitrosomethylurea in vivo. Cancer Prevention Research (Philadelphia, Pa.). 3: 640-52. PMID 20424134 DOI: 10.1158/1940-6207.Capr-09-0170  0.38
2008 Zhang X, Zarbl H. Chemopreventive doses of methylselenocysteine alter circadian rhythm in rat mammary tissue. Cancer Prevention Research (Philadelphia, Pa.). 1: 119-27. PMID 19122877 DOI: 10.1158/1940-6207.Capr-08-0036  0.336
2008 Mikheev AM, Mikheeva SA, Maxwell JP, Rivo JV, Rostomily R, Swisshelm K, Zarbl H. Dickkopf-1 mediated tumor suppression in human breast carcinoma cells. Breast Cancer Research and Treatment. 112: 263-73. PMID 18157634 DOI: 10.1007/S10549-007-9867-2  0.331
2007 Olsavsky KM, Page JL, Johnson MC, Zarbl H, Strom SC, Omiecinski CJ. Gene expression profiling and differentiation assessment in primary human hepatocyte cultures, established hepatoma cell lines, and human liver tissues. Toxicology and Applied Pharmacology. 222: 42-56. PMID 17512962 DOI: 10.1016/J.Taap.2007.03.032  0.31
2007 Page JL, Johnson MC, Olsavsky KM, Strom SC, Zarbl H, Omiecinski CJ. Gene expression profiling of extracellular matrix as an effector of human hepatocyte phenotype in primary cell culture. Toxicological Sciences : An Official Journal of the Society of Toxicology. 97: 384-97. PMID 17329237 DOI: 10.1093/Toxsci/Kfm034  0.351
2007 Mikheev AM, Mikheeva SA, Rostomily R, Zarbl H. Dickkopf-1 activates cell death in MDA-MB435 melanoma cells. Biochemical and Biophysical Research Communications. 352: 675-80. PMID 17141200 DOI: 10.1016/J.Bbrc.2006.11.079  0.31
2006 Ricicki EM, Luo W, Fan W, Zhao LP, Zarbl H, Vouros P. Quantification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl adducts in human lymphoblastoid TK6 cells dosed with N-hydroxy-4-acetylaminobiphenyl and their relationship to mutation, toxicity, and gene expression profiling. Analytical Chemistry. 78: 6422-32. PMID 16970317 DOI: 10.1021/Ac0607360  0.372
2005 Bammler T, Beyer RP, Bhattacharya S, Boorman GA, Boyles A, Bradford BU, Bumgarner RE, Bushel PR, Chaturvedi K, Choi D, Cunningham ML, Deng S, Dressman HK, Fannin RD, Farin FM, ... ... Zarbl H, et al. Standardizing global gene expression analysis between laboratories and across platforms. Nature Methods. 2: 351-6. PMID 15846362 DOI: 10.1038/Nmeth754  0.306
2005 Luo W, Fan W, Xie H, Jing L, Ricicki E, Vouros P, Zhao LP, Zarbl H. Phenotypic anchoring of global gene expression profiles induced by N-hydroxy-4-acetylaminobiphenyl and benzo[a]pyrene diol epoxide reveals correlations between expression profiles and mechanism of toxicity. Chemical Research in Toxicology. 18: 619-29. PMID 15833022 DOI: 10.1021/Tx049828F  0.362
2005 Bahramian MB, Zarbl H. GENE impedance: a natural process for control of gene expression and the origin of RNA interference. Journal of Theoretical Biology. 233: 301-14. PMID 15652140 DOI: 10.1016/J.Jtbi.2004.10.007  0.372
2005 Bahramian MB, Zarbl H. Erratum to “GENE impedence: A natural process for control of gene expression and the origin of RNA interference”: [J. Theor. Biol. 233 (2005) 301–314] Journal of Theoretical Biology. 236: 1. DOI: 10.1016/J.Jtbi.2005.04.001  0.3
2004 Mikheev AM, Inoue A, Jing L, Mikheeva SA, Li V, Leanderson T, Zarbl H. Frequent activation of CArG binding factor-A expression and binding in N-methyl-N-nitrosourea-induced rat mammary carcinomas. Breast Cancer Research and Treatment. 88: 95-102. PMID 15538050 DOI: 10.1007/S10549-004-1280-5  0.354
2004 Mikheev AM, Mikheeva SA, Liu B, Cohen P, Zarbl H. A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation. Carcinogenesis. 25: 47-59. PMID 14555616 DOI: 10.1093/Carcin/Bgg190  0.378
2001 Zarbl H, Mikheev A, Sullivan R. Patterns of gene expression in mammary cells following carcinogen exposure of strains of rat sensitive or resistant to carcinogenesis Nature Genetics. 27: 98-98. DOI: 10.1038/87380  0.309
2000 Mikheev AM, Mikheev SA, Zhang Y, Aebersold R, Zarbl H. CArG binding factor A (CBF-A) is involved in transcriptional regulation of the rat Ha-ras promoter Nucleic Acids Research. 28: 3762-3770. PMID 11000268 DOI: 10.1093/Nar/28.19.3762  0.316
1999 Bahramian MB, Zarbl H. Transcriptional and posttranscriptional silencing of rodent α1(I) collagen by a homologous transcriptionally self-silenced transgene Molecular and Cellular Biology. 19: 274-283. PMID 9858551 DOI: 10.1128/Mcb.19.1.274  0.378
1996 Cha RS, Guerra L, Thilly WG, Zarbl H. Ha-ras-1 oncogene mutations in mammary epithelial cells do not contribute to initiation of spontaneous mammary tumorigenesis in rats Carcinogenesis. 17: 2519-2524. PMID 8968072 DOI: 10.1093/Carcin/17.11.2519  0.325
1994 Cha RS, Thilly WG, Zarbl H. N-nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hras1 gene mutations Proceedings of the National Academy of Sciences of the United States of America. 91: 3749-3753. PMID 8170982 DOI: 10.1073/Pnas.91.9.3749  0.339
1994 Bahramian MB, Zarbl H. Direct gene quantitation by PCR reveals differential accumulation of ectopic enzyme in Rat-1 cells, v-fos transformants, and revertants Pcr Methods and Applications. 4: 145-153. PMID 7580898 DOI: 10.1101/Gr.4.3.145  0.385
1993 Cha RS, Zarbl H, Keohavong P, Thilly WG. Mismatch amplification mutation assay (MAMA): application to the c-H-ras gene. Pcr Methods and Applications. 2: 14-20. PMID 1490171 DOI: 10.1101/Gr.2.1.14  0.321
1992 Kho CJ, Zarbl H. Fte-1, a v-fos transformation effector gene, encodes the mammalian homologue of a yeast gene involved in protein import into mitochondria Proceedings of the National Academy of Sciences of the United States of America. 89: 2200-2204. PMID 1549582 DOI: 10.1073/Pnas.89.6.2200  0.37
1991 Boylan MO, Zarbl H. Transformation effector and suppressor genes Journal of Cellular Biochemistry. 46: 199-205. PMID 1774222 DOI: 10.1002/Jcb.240460303  0.341
1991 Zarbl H, Kho CJ, Boylan MO, Van Amsterdam J, Sullivan RC, Hoemann CD, Afshani VL. Functional in vitro assays for the isolation of cell transformation effector and suppressor genes. Environmental Health Perspectives. 93: 83-9. PMID 1685446 DOI: 10.1289/Ehp.919383  0.629
1990 Hoemann CD, Zarbl H. Use of revertant cell lines to identify targets of v-fos transformation-specific alterations in gene expression. Cell Growth & Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 1: 581-90. PMID 2126949  0.597
1987 Zarbl H, Latreille J, Jolicoeur P. Revertants of v-fos-transformed fibroblasts have mutations in cellular genes essential for transformation by other oncogenes. Cell. 51: 357-69. PMID 3664639 DOI: 10.1016/0092-8674(87)90632-5  0.553
1986 Dandekar S, Sukumar S, Zarbl H, Young LJ, Cardiff RD. Specific activation of the cellular Harvey-ras oncogene in dimethylbenzanthracene-induced mouse mammary tumors. Molecular and Cellular Biology. 6: 4104-8. PMID 3099168 DOI: 10.1128/Mcb.6.11.4104  0.313
1986 Zarbl H, Sukumar S, Arthur AL, Martin-Zanca D, Barbacid M. Activation of H-ras-1 oncogenes by chemical carcinogens. Basic Life Sciences. 38: 385-97. PMID 3017289 DOI: 10.1007/978-1-4615-9462-8_42  0.336
1984 Lemieux R, Zarbl H, Millward S. mRNA discrimination in extracts from uninfected and reovirus-infected L-cells Journal of Virology. 51: 215-222. PMID 6328041 DOI: 10.1128/Jvi.51.1.215-222.1984  0.704
1981 Skup D, Zarbl H, Millward S. Regulation of translation in L-cells infected with reovirus Journal of Molecular Biology. 151: 35-55. PMID 7328654 DOI: 10.1016/0022-2836(81)90220-5  0.718
1980 Zarbl H, Hastings KE, Millward S. Reovirus core particles synthesize capped oligonucleotides as a result of abortive transcription Archives of Biochemistry and Biophysics. 202: 348-360. PMID 7458325 DOI: 10.1016/0003-9861(80)90437-3  0.702
1980 Zarbl H, Skup D, Millward S. Reovirus progeny subviral particles synthesize uncapped mRNA Journal of Virology. 34: 497-505. PMID 7373718 DOI: 10.1128/Jvi.34.2.497-505.1980  0.694
Show low-probability matches.